Jaime Bosch - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Jaime Bosch

Showing results (331-340 of 364) with videos related to

Pageof 37

Sort By:

Microbiome|March 11, 2022

Microbiome function predicts amphibian chytridiomycosis disease dynamicsKieran A Bates, Ulf Sommer, Kevin P Hopkins, et al.

Clinical Transplantation|September 20, 2018

Impact of hepatic encephalopathy on liver transplant waiting list mortality in regions with different transplantation ratesAnnarein J C Kerbert, Enric Reverter, Lara Verbruggen, et al.

JHEP Reports : Innovation in Hepatology|May 8, 2023

Increased sinusoidal pressure impairs liver endothelial mechanosensing, uncovering novel biomarkers of portal hypertensionMartí Ortega-Ribera, Albert Gibert-Ramos, Laia Abad-Jordà, et al.

Journal of Hepatology|August 26, 2018

The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment optionsZobair Younossi, Maria Stepanova, Arun J Sanyal, et al.

Hepatology (Baltimore, Md.)|August 3, 2013

Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case-control studyCristina Ripoll, Joan Genescà, Isis K Araujo, et al.

Proceedings of the National Academy of Sciences of the United States of America|November 9, 2011

Multiple emergences of genetically diverse amphibian-infecting chytrids include a globalized hypervirulent recombinant lineageRhys A Farrer, Lucy A Weinert, Jon Bielby, et al.

Journal of Hepatology|October 25, 2025

Refining the Baveno VII criteria for clinically significant portal hypertension: An individual patient data meta-analysisJuan Bañares, Mònica Pons, Thomas Reiberger, et al.

Journal of Hepatology|December 25, 2019

Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertensionGuadalupe Garcia-Tsao, Jaime Bosch, Zeid Kayali, et al.

Transplantation|July 21, 2022

Donor Simvastatin Treatment Is Safe and Might Improve Outcomes After Liver Transplantation: A Randomized Clinical TrialDuilio Pagano, Jaime Bosch, Fabio Tuzzolino, et al.

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 9, 2019

Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-AnalysisLaura Turco, Candid Villanueva, Vincenzo La Mura, et al.

Pageof 37

Search research articles

Showing results (331-340 of 364) with videos related to

Sort By:

Pageof 37

Microbiome|March 11, 2022

Microbiome function predicts amphibian chytridiomycosis disease dynamicsKieran A Bates, Ulf Sommer, Kevin P Hopkins, et al.

Clinical Transplantation|September 20, 2018

Impact of hepatic encephalopathy on liver transplant waiting list mortality in regions with different transplantation ratesAnnarein J C Kerbert, Enric Reverter, Lara Verbruggen, et al.

JHEP Reports : Innovation in Hepatology|May 8, 2023

Increased sinusoidal pressure impairs liver endothelial mechanosensing, uncovering novel biomarkers of portal hypertensionMartí Ortega-Ribera, Albert Gibert-Ramos, Laia Abad-Jordà, et al.

Journal of Hepatology|August 26, 2018

The conundrum of cryptogenic cirrhosis: Adverse outcomes without treatment optionsZobair Younossi, Maria Stepanova, Arun J Sanyal, et al.

Hepatology (Baltimore, Md.)|August 3, 2013

Rebleeding prophylaxis improves outcomes in patients with hepatocellular carcinoma. A multicenter case-control studyCristina Ripoll, Joan Genescà, Isis K Araujo, et al.

Proceedings of the National Academy of Sciences of the United States of America|November 9, 2011

Multiple emergences of genetically diverse amphibian-infecting chytrids include a globalized hypervirulent recombinant lineageRhys A Farrer, Lucy A Weinert, Jon Bielby, et al.

Journal of Hepatology|October 25, 2025

Refining the Baveno VII criteria for clinically significant portal hypertension: An individual patient data meta-analysisJuan Bañares, Mònica Pons, Thomas Reiberger, et al.

Journal of Hepatology|December 25, 2019

Randomized placebo-controlled trial of emricasan for non-alcoholic steatohepatitis-related cirrhosis with severe portal hypertensionGuadalupe Garcia-Tsao, Jaime Bosch, Zeid Kayali, et al.

Transplantation|July 21, 2022

Donor Simvastatin Treatment Is Safe and Might Improve Outcomes After Liver Transplantation: A Randomized Clinical TrialDuilio Pagano, Jaime Bosch, Fabio Tuzzolino, et al.

Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 9, 2019

Lowering Portal Pressure Improves Outcomes of Patients With Cirrhosis, With or Without Ascites: A Meta-AnalysisLaura Turco, Candid Villanueva, Vincenzo La Mura, et al.

Pageof 37